chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccine 10/16/10 at walk in offering.  On 10/24/10 patient described progressive weakness, dificulty walking, low back pain, numbness in arms and feet.  Presented to Hospital Emergency Department.  Admitted to ICU 10/25/2010.  Currently sedated and intubated.  Findings/admission reported to Pharmacist filling out this report.
22 hours after injection, slight headache, followed by whole body aches and joint pain lasting for 18 hours.  Felt like standard flu symptoms at most intense period with very low energy and feeling of chills and fever, though non present.  Following morning whole body aches gone, but slight knee joint aches persisted until noon.
Generalized hives, given 14 day Prednisone taper, ZYRTEC and BENADRYL.
I got sick for 48 hours after vaccine (headache, chills, aches, primarily) but then got better for several days later.  A week later I started getting severe headaches (never had headache issues before in my life).   It go so bad I could not open my eyes for basically a day.  Went to the ER after I developed a fever.  They tested me for covid and it came back negative.  They gave me an IV and sent me on my way.  Said I was just having a bad cold.  Symptoms did not get better and in fact got worse.  I couldn't open my eyes again because of the headaches and I noticed a rash.  Went back to the ER, they tested me for covid (negative) and said it was a virus.  Sent me on my way again.  Symptoms didn't get better... went to Urgent Care and they tested for covid (negative) and strept.  Strept test came back positive.   Got me medication and I went home.  Headaches still would not go away and my rash had gotten worse.  I went back to the same Urgent Care and they said you are having a bad reaction to the vaccine and have shingles because of it.  Gave me more medication... eventually I got better.  I still have headaches to this day (which again, never had before).  Very frustrating but it is what it is at this point.
Around 3 to 5 pm had no balance felt over.; extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Around 3 to 5 pm had no balance felt over.) and FATIGUE (extremely tired) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Peanut allergy (Patient had no allergy reaction with vaccine but had reacted to peanuts on one occasion years ago), Blood pressure high and Cholesterol.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced BALANCE DISORDER (Around 3 to 5 pm had no balance felt over.) and FATIGUE (extremely tired). On 06-Mar-2021, BALANCE DISORDER (Around 3 to 5 pm had no balance felt over.) had resolved. At the time of the report, FATIGUE (extremely tired) had resolved.            The patient is taking medication for blood pressure twice a day and for cholesterol. On follow-up, the patient reported that post vaccine difficulties were misreported and that he had no reaction at all at the time of the injection and thereafter.   Most recent FOLLOW-UP information incorporated above includes:
Pt received Hepatitis A & typhoid @ 1:30pm her mom called @ 3pm stated her daughter was having a reaction c/o sob,headache dizziness, nausea and abdominal pain, pt instructed to go straight to emergency room
fever 105, measles rash 9 days later on 12/15/05.  12/16 fever 101 doing better coloring erythemitis plaques on entire body spreading to legs.
Case number PHEH2014US013809, is a combined initial and follow up spontaneous report from a consumer received on 07 Jul 2014 and 10 Jul 2014 respectively and a follow up received from consumer on 19 Aug 2014, with a follow up received from physician on 08 Oct 2014. This report refers to an approximately 72 year old elderly male patient. The physician reported that the patient does not have any history of GBS or other neurological diseases or other significant medical history. No concomitant medication was reported. He was vaccinated with FLUVIRIN (batch number: 1309401, expiration date: Apr 2014) on 21 Oct 2013. On an unknown date after vaccination, he experienced Guillain-Barre syndrome and he was paralyzed on his left side and the paralysis was flaccid. It was reported that FLUVIRIN almost killed him and he was still experiencing problems due to FLUVIRIN administration. The physician stated that the onset of the event was progressive over several weeks noticing, weakness in extremities requiring hospitalization and lumbar puncture. There was no respiratory muscle involvement; no cranial nerve involvement and deep tendon reflex were absent. The electromyogram and nerve conduction studies revealed symmetric, sensory, motor axonal polyneuropathy; active denervation was seen in distal muscles in the right lower extremity and are consistent with the GBS. He had elevated protein levels found in CSF. There was no differential diagnosis. The patient was getting stronger. Treatment was rendered with intravenous immunoglobulin G and steroids intravenous. The final outcome of the events was complete recovery. The seriousness of the events was reported as life threatening, hospitalization, disability and medically significant. The physician stated that they did not administer FLUVIRIN to the patient and do not have any information about the FLUVIRIN injection itself. The physician reported that they are a neurology office that took care of the patient after he developed Guillain Barre Syndrome and believed that Guillain Barre Syndrome was due to FLUVIRIN. Non-significant follow up received from consumer on 19 Aug 2014: updated physician contact information. Follow up received from physician on 08 Oct 2014: updated patient demographics, lab data, new events, seriousness of the events, outcome of the events, treatment and other clinically relevant information in the narrative.
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/20/2021 and 2/10/2021. On 7/27/2021, patient presents to the ED with weakness and fatigue after being diagnosed with COVID-19 1 day prior. On arrival to the ED, patient O2 saturation 88%, 2LNC initiated. Patient admitted to the hospital for COVID-19, hypoxemia, and elevated troponin. Patient received remdesivir x 5 days, convalescent plasma 1 unit, tocilizumab 800 mg x 1 dose, dexamethasone, azithromycin, ceftriaxone. Patient developed new onset atrial fibrillation on 8/7/2021. Throughout hospitalization patient continued to decompensate and eventually expired on 8/8/2021.
L arm with swelling, redness, warmth, and tenderness. Treated with benadryl, motrin, and Zyrtec
6/2 received multiple immunizations. On 6/3, decrease appetite/activity. 4pm spiked fever 103 and given Tylenol. 7pm had tonic-colic seizure lasting approx. 1 min. some postictal lethargy. Parents took to ER for eval. in ER is alert, oriented and acting normally. No other sx. CBC/chemistries normal. Observed for several hours. No tx.d/c'd to home. Simple febrile convulsion. Return to ER if another seizure o/w, follow up with PCP .
My feet started itching three days after shot and then I seen my sling began sloughing off. The next morning my feet are burning uncontrollably and still real tender
Under age administration of Pfizer COVID-19 vaccine.  Recipient is under the age of 12.  Recipient's parents did sign consent form.  They will be notified that recipient should not return for second dose.
10am Pt c/o SOB, tightness in chest, left arm numbness, dizziness.  BP 127/84  P-108 PO 100%.  RN came to assist.  10:04am Benadryl 25 mg liquid given PO BP121/73 P 104 PO 97%.  Left arm injection site asymptomatic.  Pt states this is her 2nd Covid vaccine and did not react to the first one.  Pt states she had anaphylactic reactions to PCN, ASA, Sulfa, Keflex and Codeine in the past.  C/O blurred vision. 10:10am BP 132/81 p 112 PO 98% with same symptoms. RN present and we discussed going to ER, vs stable and patient declined going. 10:15am BP 133/82 P-114 PO 96%, pt states her breathing is better, thinks the Benadryl caused the dizziness, continued blurred/fuzzy vision, not double vision, A & O x3. 10:20am BP 127/83 P-108 PO98% denies SOB and chest tightness, states she feels better.  Crackers, juice and water given.  10:25am BP 123/83 P 105 PO 98% pt states blurred vision has gone. 10:30am BP 129/70 P 105 PO 97% continue to feel better.  Talking to her co-worker about getting a ride back to work with her after she receives her vaccine.  10:55am BP 120/72 P 105 Sat 99% went to restroom with another nurse and states she feels fine standing. 11am BP 126/75 P98 PO 98% denies arm numbness, blurred vision and SOB/chest tightness. Report off to 11am Volunteer RN for the monitor room.
Significant swelling, pain, redness to injection site which began 3 days after vaccine.  Pain rotated under arm and radiated to Lt breast.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was provided regarding medical history, concurrent condition, or concomitant medication. In 2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose number and route was not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date (reported as "subsequent to zoster vaccine live (ZOSTAVAX) inoculation"), the patient was treated by a physician for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.
A few days after receiving the first dose of the Moderna Vaccine my existing tinnitus became more persistent and  much louder. I now have a continuous  loud buzzing that never stops and is more annoying than before and affecting my hearing,
Random shortness of breath and inability to get a normal breath of air as constricted by lung capacity. Occasional random extreme exhaustion and have to lay down and sleep. I believe knee and joint pain and early menopause due to inactive ovary is also a result of vaccines since this condition does not run in my family, and I am the only one in my family to be in the military and received all these vaccines.
Feels dizzy, syncopal episode, blood pressure drop, sweaty. BP monitor by paramedics  and stay low, was transported to an area hospital emergency room or follow-up
Information has been received from a physician concerning a school aged patient who was vaccianted with a dose of varicella virus vaccine live. It was noted that the child was exposed to zoster from a household contact. Subsequently, the child developed chickenpox. The case was noted to be a mild case of chickenpox with less than 50 lesions. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
I have a 101 fever; I am not really feeling well; This is a spontaneous report from a contactable consumer (patient herself). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK923; expiry date: Apr2021) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced 101 fever and was not really feeling well. Outcome of the events was unknown.
I received the vaccination I also got the Flu vaccine at the same time; I received the vaccination I also got the Flu vaccine at the same time; I was horribly sick; body ache; high, high fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 31Oct2022 at 10:40 as dose 5 (booster), single (Lot number: GJ6665, Expiration Date: 30Jun2023) at the age of 55 years for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 31Oct2022 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing), notes: I have Asthma and I do not want to go too far on my own medical history.". The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; UNKNOWN MANUFACTURER), for Covid-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); UNKNOWN MANUFACTURER), for Covid-19 immunization; Covid-19 vaccine (DOSE 4 (BOOSTER); UNKNOWN MANUFACTURER), for Covid-19 immunization; Covid-19 vaccine (DOSE 2; UNKNOWN MANUFACTURER), for Covid-19 immunization. The following information was reported: ILLNESS (non-serious) with onset 2022, outcome "unknown", described as "I was horribly sick"; PAIN (non-serious) with onset 2022, outcome "unknown", described as "body ache"; PYREXIA (non-serious) with onset 2022, outcome "unknown", described as "high, high fever"; OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 31Oct2022, outcome "unknown" and all described as "I received the vaccination I also got the Flu vaccine at the same time". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of illness, pain, pyrexia.  Additional information: the patient did not had any investigations in last two weeks. It was reported as I was horribly sick starting Tuesday to somewhat today but you now very, very situation better then now (at the time of report). The patient was treated with Tylenol cold and Ibuprofen. The patient I think it was my left arm, but they did one on the one side and one in the other, so I am not sure which one went where but it was top of arm." For Anatomical site of administration it was reported as I think it was my left arm, but they did one on the one side and one in the other, so I am not sure which one went where but it was top of arm.
Client inadvertently received Varicella 3/6/12 at 6 pm instead of zoster. Med. Director said to give in am (zoster). Client received zoster at 8:15 am 3/7/12. On 7/2/12 has PA called, stating client has fever & chills 3 weeks and feels it's from varicella/zoster given too close together. Med. Director notified & feels this isn't the cause of chills/fever and to call PA in 10 days for titer results.
An expired vaccine was administered (12/31/2021).  No adverse event is being reported by the patient.
Taste is slightly off; Constant face, nose, and upper jaw numbness; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Taste is slightly off) and HYPOAESTHESIA (Constant face, nose, and upper jaw numbness) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced TASTE DISORDER (Taste is slightly off) and HYPOAESTHESIA (Constant face, nose, and upper jaw numbness). At the time of the report, TASTE DISORDER (Taste is slightly off) and HYPOAESTHESIA (Constant face, nose, and upper jaw numbness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient declined to provide concomitant medications name, the patient takes the same medications for years.  No treatment information was provided.
This case was reported by a consumer (the subject's mother) and described the occurrence of cold in a 8-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included asthma. Concurrent medications included inhaler. On 17 September 2011 the subject received a dose of FLULAVAL (unknown route, left arm), and experienced wrong vaccine administered. The subject was younger than the indicated age for administration of FLULAVAL. On 07 October 2011, 20 days after vaccination with FLULAVAL, the subject experienced cold, cough and runny nose. At the time of reporting the outcome of the events was unspecified. The consumer reported that her two children had experienced adverse events after vaccination with FLULAVAL. See case ID A0949172A for details of the other report. Follow-up received from a healthcare professional on 07 October 2011: The healthcare professional  reported that the subject received FLULAVAL vaccination at the father's work clinic. The healthcare professional reported the maladministration only and did not provide any adverse event information.
Vomiting, diarrhea, overall pain, tightness around heart for 12 hours
Injection site reaction of swelling, redness, hot, and painful. Redness persisted 4 days and went 3/4 around upper arm. Tempature of 101 on day 3 with chills and nausea. Day 2 swelling was 4.5 in x 3 in. Day 3 redness increased to 7 in x 5 in.
4 days after injection: Soreness in arm, swollen and painful lymph node in armpit until evening  of 1/6/21.  1/5/21 (1 week after injection), 5pm: swelling,  redness, burning, hardened tissue around injection site on left shoulder. 1/6/21: Worsened swelling, redness, hardened tissue which continued to cover upper arm. Turned into hives (first time ever having that kind of allergic reaction).  Took a Benedryl before bed. 1/7/21: symptoms improved by at least 50%. Much less pain in armpit. Redness and some tenderness still present in left shoulder. Another Benedryl taken this morning.
2/20/19: Dr. reviewed at length the Sx C/W viral pattern and typical course of illness and if Sx progress may need to evaluate further for possible measles - measles seen at this time in community, surrounding area. No known exposure but will need to watch closely. We reviewed findings of concern and also findings to watch for and follow. Will have her seen tomorrow to reassess. 2/21/19: Here for follow up of illness  Six days ago began with fever, up to 102, which lasted for three days. Has had cough, congestion, slightly watery eye, and nasal discharge for the past six days. Rash began 2 nights ago on trunk and then spread to face and scalp. 1 tiny erythematous papule on R thumb, but no palm or sole involvement. No lymphadenopathy. The rash has changed since yesterday, and now the spots on her chest and abdomen are non-blanching and no longer erythematous (more a light purple). Slight red spots in her mouth. She has bilateral serous otititis, but no purulent fluid behind TMs. Her lung exam is normal. Based on these symptoms, I obtained a respiratory viral panel and check for mycoplasma by PCR.  Mycoplasma was negative, but respiratory pathogen panel was positive for Coronavirus 229E.  Given her level of fussiness, I question whether this virus is solely responsible for her symptoms.  I discussed Patient's case with Dr. of Pediatric Infectious Disease. Due to her symptoms and recent cases of measles in State, she recommended testing for measles--will obtain Rubeola IgM, Rubeola IgG, as well as measles culture and PCR(nasopharyngeal swab). She also advised testing a repeat CBC (to monitor her platelets) and hepatic function panel. Patient will come back to the office this afternoon. I discussed the above with pt's mother over the phone and with our nurse supervisor (LVN). 2/22/19: Still fussy, but better than yesterday. Rash slowly improving. Some nonblanching light purple macules. Still congested. Mouth no longer with erythematous dots. LOM-Rx amoxicillin, RSOM. Repeat CBC yesterday showed largely unchanged WBCs, platelets went up to 210 from 160's, and LFTs showed very slightly elevated AST (ALT normal). She looks improved compared to yesterday besides the new LOM.  Will treat LOM with amoxicillin as below. Follow up on Monday (3 days) or sooner if new fever, worsening symptoms, dark purple spots, breathing difficulty, worsening fussiness or any other concerns.
Not feeling well; This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis and PNEUMOCOCCAL VACCINE for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix, Influenza vaccine Quadrivalent unspecified season and PNEUMOCOCCAL VACCINE. On an unknown date, unknown after receiving Shingrix and Influenza vaccine Quadrivalent unspecified season, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was recovered/resolved.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix and Influenza vaccine Quadrivalent unspecified season.  Additional information was provided as follows: The case was reported by patient's mother. The age at vaccination was not reported. The age group was captured as an adult as per vaccine indication. The patient received first dose of Shingrix at an unspecified time along with flu and pneumonia shot and was not feeling well for two days. The reporter consented to follow up. For tolerance of 2nd dose, refer case US2020AMR212682. This was 1 of the 4 cases, reported by same reporter. Caller declined to provide PII. Limited information provided.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020212040:same reporter US-GLAXOSMITHKLINE-US2020AMR212682:same reporter
I'm experiencing extreme fatigue, shortness of breath, excruciating headache, muscle aches, sniffles, and hot and cold. My head never hurt like this and my heart rate is up to 117. This has been going on since about 6:00p.m. Yesterday 01/25/2022.
vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022, the patient experienced VERTIGO (vertigo). At the time of the report, VERTIGO (vertigo) outcome was unknown.            No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
Left arm swelled to 3x size. Became hard and injection site and hot. Pt developed fever and body aches. Than in morning he began to vomit.